The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021

被引：0
|
作者：
Chen Li
Jun Hao
Yitian Zheng
Chuangshi Wang
Jie Yang
Wenyao Wang
Kuo Zhang
Chunli Shao
Wen Hui
Jiancheng Wang
Wei Li
Yi-Da Tang
机构：
[1] Chinese Academy of Medical Sciences,Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College
[2] National Clinical Research Center for Cardiovascular Diseases,Medical Research and Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College
[3] Chinese Academy of Medical Sciences,Department of Cardiology, Institute of Vascular Medicine, Key Laboratory of Molecular Cardiovascular Science
[4] Peking University Third Hospital,Department of Science and Technology, West China Hospital
[5] Ministry of Education,Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences
[6] Sichuan University,Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases
[7] Peking University,undefined
[8] Chinese Academy of Medical Sciences,undefined
来源：
Diabetology & Metabolic Syndrome | / 15卷
关键词：
Cardiometabolic disease; China; Drug clinical trial; Changing landscape;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009-2021
    Li, Chen
    Hao, Jun
    Zheng, Yitian
    Wang, Chuangshi
    Yang, Jie
    Wang, Wenyao
    Zhang, Kuo
    Shao, Chunli
    Hui, Wen
    Wang, Jiancheng
    Li, Wei
    Tang, Yi-Da
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [2] The changing landscape of clinical trials for mitochondrial diseases: 2011 to present
    Khayat, Delia
    Kurtz, Tracie L.
    Stacpoole, Peter W.
    [J]. MITOCHONDRION, 2020, 50 : 51 - 57
  • [3] ORIGINAL RESEARCH Changes in Drug Clinical Trials of Thyroid Diseases in China, 2009-2022
    Li, Chen
    Hao, Jun
    Wang, Chuangshi
    Yang, Jie
    Zheng, Yitian
    Zhang, Kuo
    Hui, Wen
    Meng, Xiangbin
    Gao, Jun
    Li, Wei
    Tang, Yi-Da
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 2315 - 2324
  • [4] Analysis of Drug Clinical Trials for Eye Diseases in China
    Hu, Jianping
    Ma, Qian
    Xin, Chen
    Jiao, Yonghong
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 38 (09) : 645 - 653
  • [5] The changing landscape of clinical trials in Australia
    Seidler, Anna Lene
    Willson, Melina L.
    Aberoumand, Mason
    Williams, Jonathan G.
    Hunter, Kylie E.
    Barba, Angie
    Simes, R. John
    Webster, Angela
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2023, 219 (05) : 192 - 196
  • [6] The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020
    Zhong, Qiaofeng
    Tao, Yunxia
    Chen, Haizhu
    Zhou, Yu
    Huang, Liling
    Han, Xiaohong
    Shi, Yuankai
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2021, 11
  • [7] Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021
    Jun Hao
    Chen Li
    Junrong Li
    Chuangshi Wang
    Yang Li
    Chen He
    Weida Liu
    Sidong Li
    Ling Zuo
    Wen Hui
    [J]. American Journal of Cardiovascular Drugs, 2023, 23 : 301 - 310
  • [8] Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021
    Hao, Jun
    Li, Chen
    Li, Junrong
    Wang, Chuangshi
    Li, Yang
    He, Chen
    Liu, Weida
    Li, Sidong
    Zuo, Ling
    Hui, Wen
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (03) : 301 - 310
  • [9] Trend of drug clinical trials in mainland China from 2009 to 2020
    Cao, Yu
    Liao, Lianming
    Liu, Xin
    Zheng, Qingshan
    Xu, Zhongyuan
    Niu, Haitao
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (09) : 1499 - 1507
  • [10] Changing landscape of clinical cancer trials in Germany
    Burock, S.
    Fuereder, T.
    Schauer, S.
    Keilholz, U.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 674 - 674
12345